Sign In

Pat Arensdorf

Co-Founder and Chief Executive Officer at Exai Bio

Pat Arensdorf is an accomplished professional with a diverse educational background and a rich history of leadership roles in various organizations.

A graduate of Princeton University with a Bachelor's degree in Molecular Biology, Pat furthered his education by pursuing an Advanced Project Management Program at Stanford University and earning a Masters in Management as a Sloan Fellow at Stanford University Graduate School of Business.

Throughout his career, Pat has held numerous significant positions like Co-Founder and CEO at Exai Bio, Principal at Halteres Associates, and Startup CFO at Chan Zuckerberg Biohub.

With experience as a CEO at companies such as Bluestar Genomics, Inc and Critical Diagnostics, Pat has showcased his skills in Precision Epigenomic Medicine and strategic management.

His expertise extends to roles such as General Manager of the Heart Failure Business Unit at Diadexus, Executive Vice President at Moerae Matrix, and Chief Executive Officer at First Medical, highlighting his versatile capabilities across different industry sectors.

Having served in executive positions at Intersect ENT, Tethys Bioscience, and Zilkha & Company, Pat has demonstrated a keen business acumen and leadership in strategy development and corporate growth.

With a strong educational foundation and a wealth of experience in the biotechnology and healthcare sectors, Pat Arensdorf is a seasoned professional known for his contributions to the industry.

His advisory roles at ImmuMetrix and Conversion Capital Management reflect his versatile skill set and strategic insight, making him a valuable asset in the business world.

Pat Arensdorf
Add to my network

Location

Palo Alto, California, United States